HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. International Trade Commission (USITC) regarding supply chain challenges related to COVID-19 and critical medical products. HSCA appreciates the Commission’s leadership and efforts to-date to help identify COVID-related materials and goods and increase access to these essential supplies. Through collaboration and efforts to further strengthen supply chain resilience, we can best support our nation’s healthcare providers and overall preparedness. HSCA is committed to supporting patient care and ensuring healthcare providers are equipped to respond to emergencies and public health crises like the COVID-19 pandemic.
Click here to read the full comments.
New Analysis of U.S. Health Data Finds Healthcare Group Purchasing Organizations Save Healthcare System, Medicare and Medicaid, and Taxpayers Up to $34.1 Billion Annually
Analysis of CMS expenditure data finds that GPOs will reduce healthcare spending...
Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...